MC-VC-PAB-NH2 TFA incorporates a modular cleavable linker system frequently evaluated in controlled-release and protease-cleavage studies. Val-Cit and PAB components shape enzymatic specificity. Researchers analyze its stability, solubility, and kinetic behavior. Applications include prodrug-linker research, reaction monitoring, and controlled-delivery modeling.
CAT No: R2697
CAS No:1616727-21-9
Synonyms/Alias:MC-VC-PAB-NH2 TFA;1616727-21-9;MC-VC-PAB-NH2 (TFA);EX-A8193E;HY-136132A;DA-55297;CS-0311313;[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-(2-aminoethyl)carbamate;2,2,2-trifluoroacetic acid;L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[(2-aminoethyl)amino]carbonyl]oxy]methyl]phenyl]-, 2,2,2-trifluoroacetate (1:1);
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.